TAO SHEN to Tumor Microenvironment
This is a "connection" page, showing publications TAO SHEN has written about Tumor Microenvironment.
Connection Strength
0.630
-
Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation. Front Immunol. 2025; 16:1540578.
Score: 0.162
-
A Powerful Organic Photosensitizer for Effective Treatment of Malignant Tumors Via Activating Antitumor Immunity. Chembiochem. 2025 Feb 03; 26(5):e202400975.
Score: 0.162
-
Multi-omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma. BMC Cancer. 2024 Sep 12; 24(1):1138.
Score: 0.158
-
Divergent Roles of C/EBP? Isoforms LAP and LIP in Shaping T Cell Dysfunction and Tumor Progression in Triple-Negative Breast Cancer. FASEB J. 2025 Aug 31; 39(16):e70984.
Score: 0.042
-
Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma. Int J Med Sci. 2025; 22(10):2488-2501.
Score: 0.041
-
Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Front Immunol. 2023; 14:1155182.
Score: 0.036
-
Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. J Immunother Cancer. 2020 02; 8(1).
Score: 0.029